Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of regulating intestinal microbiota on anxiety symptoms: A systematic review
Beibei Yang, Jinbao Wei, Peijun Ju, et al.
General Psychiatry (2019) Vol. 32, Iss. 2, pp. e100056-e100056
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 743
Autism-related dietary preferences mediate autism-gut microbiome associations
Chloe X. Yap, Anjali K. Henders, Gail A. Alvares, et al.
Cell (2021) Vol. 184, Iss. 24, pp. 5916-5931.e17
Open Access | Times Cited: 252
Safety assessment of titanium dioxide (E171) as a food additive
Maged Younes, Gabriele Aquilina, Laurence Castle, et al.
EFSA Journal (2021) Vol. 19, Iss. 5
Open Access | Times Cited: 220
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 65
Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan
Shikha Snigdha, Kevin Ha, Paul Tsai, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107978-107978
Closed Access | Times Cited: 96
Gut microbes in neurocognitive and mental health disorders
Tyler Halverson, Kannayiram Alagiakrishnan
Annals of Medicine (2020) Vol. 52, Iss. 8, pp. 423-443
Open Access | Times Cited: 89
Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications
George Anderson, Michaël Maes
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 7, pp. 524-539
Closed Access | Times Cited: 88
Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain
Haoming Xu, Hong‐Li Huang, Youlian Zhou, et al.
Gastroenterology Research and Practice (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 74
Exposure to greenspaces could reduce the high global burden of pain
Jessica Stanhope, Martin F. Breed, Philip Weinstein
Environmental Research (2020) Vol. 187, pp. 109641-109641
Open Access | Times Cited: 70
Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
Rima Hajjo, Dima A. Sabbah, Abdel Qader Al Bawab
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1742-1742
Open Access | Times Cited: 48
Understanding the Complexities and Changes of the Astronaut Microbiome for Successful Long-Duration Space Missions
Donatella Tesei, Anna Jewczynko, Anne M. Lynch, et al.
Life (2022) Vol. 12, Iss. 4, pp. 495-495
Open Access | Times Cited: 41
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
Gianluca Quaranta, Alessandra Guarnaccia, Giovanni Fancello, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2424-2424
Open Access | Times Cited: 38
Time outdoors and residential greenness are associated with reduced systemic inflammation and allostatic load
Andrey I. Egorov, Shannon M. Griffin, Jennifer N. Styles, et al.
Environmental Pollution (2024) Vol. 344, pp. 123408-123408
Closed Access | Times Cited: 8
Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency
Cuizhen Zhu, Yu Zhang, Ting Wang, et al.
Brain and Behavior (2020) Vol. 10, Iss. 11
Open Access | Times Cited: 67
The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders
Annie Tremblay, Lucie Lingrand, Morgane Maillard, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110142-110142
Open Access | Times Cited: 56
Gut microbiome-mediated epigenetic regulation of brain disorder and application of machine learning for multi-omics data analysis
Harpreet Kaur, Yuvraj Singh, Surjeet Singh, et al.
Genome (2020) Vol. 64, Iss. 4, pp. 355-371
Closed Access | Times Cited: 53
CUMS and dexamethasone induce depression-like phenotypes in mice by differentially altering gut microbiota and triggering macroglia activation
Jing Wu, Jinhang Li, Gaurav Chhetri, et al.
General Psychiatry (2021) Vol. 34, Iss. 6, pp. e100529-e100529
Open Access | Times Cited: 48
The Gut-Brain Axis and the Microbiome in Anxiety Disorders, Post-Traumatic Stress Disorder and Obsessive-Compulsive Disorder
Marnie MacKay, Bohan H. Yang, Serdar Dursun, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 866-883
Open Access | Times Cited: 16
Association between gut microbiota and anxiety disorders: a bidirectional two-sample mendelian randomization study
Jianbing Li, Changhe Fan, Jiaqi Wang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Psychobiotics Regulate the Anxiety Symptoms in Carriers of Allele A of IL-1βGene: A Randomized, Placebo-Controlled Clinical Trial
Paola Gualtieri, Marco Marchetti, Giorgia Cioccoloni, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 48
Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients
Chen Fu, Zhangran Chen, Minjie Chen, et al.
npj Biofilms and Microbiomes (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 39
Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease lead to depression?
Miloš Mitić, Tamara Lazarević‐Pašti
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 7, pp. 841-856
Closed Access | Times Cited: 34
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, et al.
General Psychiatry (2022) Vol. 35, Iss. 1, pp. e100685-e100685
Open Access | Times Cited: 25
Alteration of faecal microbiota balance related to long-term deep meditation
Ying Sun, Peijun Ju, Ting Xue, et al.
General Psychiatry (2023) Vol. 36, Iss. 1, pp. e100893-e100893
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top